Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

TAKE MORE PARTIAL PROFITS ON $INTC RIGHT HERE AT $21.12 AND TIGHTEN THE STOPS

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

Read More »

ACOR (ACORDIA) FAMPRIDINE IS NOT A VERY GOOD DRUG EVEN IF IT WORKS AS ADVERTISED

The FDA Peripheral and Central Nervous System Drugs Advisory Committee meets today to review ACOR’s Fampridine-SR for improvement of walking in patients with multiple sclerosis . We have been negative on ACOR from the very beginning of Fampridine saga because even if the drug works as ACOR promotes, it is not a very good drug. Moreover, the number of participants in ACOR studies have been relatively small compared to what we think it should be to fully evaluate the risk of seizures. We also think the studies are flawed in how they measure the walking ability. Measurement of anything in

Read More »

SHORT ON INTC (INTEL)

As per our earlier post, we are short on INTC from $21.85. Take partial profits right here at $21.36 and take more profits if the stock goes lower. Tighten the stop. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

Read More »

$CSX COMMENTARY IS NEGATIVE FOR COAL STOCKS

$CSX is a major rail carrier for coal to utilities. The commentary with earnings is negative for coal stocks. Consider opportunistically short selling with tight stops $CNX, $BTU, $ACI, and $MEE. Our other screens are bearish on coal stocks. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

Read More »

INTC (INTEL) SHORT LEVELS

In response to questions, if INTC spikes up , we will consider short selling as the stock approaches $22 and stop over $23. Of course these are the levels for a perfect trade, which is not likely. We will consider shorting at lower levels depending on details of the earnings, guidance and how the stock trades. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number

Read More »

$NUVA ( NUVASIVE ) PRESENTS A SHORT TERM TRADING OPPORTUNITY

NUVA stock has been down today on rumors that JNJ (Johnson & Johnson) will announce a lateral fusion device in the post earnings conference call. JNJ web site shows that the head of its device business will be on the call indicating there may be some truth to the rumor. NuVasive’s main business is lateral fusion devices. If there is no competing device on JNJ call, NUVA is a short term buy, otherwise it is short. The early bird catches the worm; consider listening to the call and immediately entering the position www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE

Read More »

$INTC (INTEL) IS SELL THE NEWS STORY

INTEL reports earnings next week. Commentary from the Wall Street is almost universally positive. In the middle of this bullishness, our screens, especially fund flows, show that the smart money is selling into strength. If the earnings are good, the probability is that the good earnings are the result of replenishing inventory and building additional inventory ahead of Windows 7 launch and the holiday season. If the earnings are not good in this boom inventory build up time, it is a indication of slowing demand compared to anticipation. It appears the profitable trade will be on the short side if

Read More »

CONSIDER SHORT SELL ON MDT (MEDTRONICS)

Consider start scaling in a short position in MDT right here at $36.20. MDT had passed all of our screens for a short sale, but we had been waiting for a trigger that the market pays attention to before entering the trade. Patience in entering short sales is especially important when the overall tape is ripping. Today STJ forecast significantly lower revenues and confirmed our earlier checks that hospitals have been reducing inventory of the medical devices they carry. Now we have the trigger and will add to our short position on spikes up.Various health reform bills have provisions of

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content